Autres langues Initiator Pharma A/S

Actions

INIT

DK0060775872

Marché Fermé - Nasdaq Stockholm Autres places de cotation 17:24:16 10/05/2024			Varia. 5j.	Varia. 1 janv.
9,2 ^SEK	-0,65%		0,00%	-0,43%

10/05	Initiator Pharma A/S publie ses résultats pour le premier trimestre clos le 31 mars 2024	CI
23/02	Initiator Pharma A/S publie ses résultats pour le quatrième trimestre et l'exercice clos le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Initiator Pharma Q1 2024 - Focus on sealing a deal	10/05
INITIATOR PHARMA: Q1 2024 REPORT	10/05
Initiator Pharma A/S Reports Earnings Results for the First Quarter Ended March 31, 2024	10/05
Notice to AGM in Initiator Pharma	02/05
Annual report and Remuneration report 2023 for Initiator Pharma A/S	02/05
Initiator Pharma's pudafensine preclinical pharmacology results published in the British Journal of Pharmacology	15/04
Initiator Pharma’s pudafensine preclinical pharmacology results published in the British Journal of Pharmacology	12/04
Initiator Pharma - Q4 2023 – Breathing optimism	23/02
INITIATOR PHARMA: YEAR END REPORT 2023	23/02
Initiator Pharma A/S Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	23/02
Initiator Pharma Issues New Shares for Debt Conversion	21/02
MAC Clinical Research converts its receivable into shares in Initiator Pharma	21/02
Initiator Pharma A/S - Issuance of new shares and directed share buyback, as well as the sale of shares in connection with the long-term incentive program for 2021	24/01
Issuance of new shares and directed share buyback, as well as the sale of shares in connection with the long-term incentive program for 2021	23/01
Initiator Pharma expands its position to a broader Sexual Health Franchise and intensifies its business development efforts	08/01
Initiator Pharma A/S Expands Its Position to Broader Sexual Health Franchise and Intends Business Development Efforts	08/01
Initiator Pharma Q3 - A historical quarter	10/11
Initiator Pharma A/S Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	10/11
Initiator Pharma reports positive statistically significant and clinically relevant Phase IIb efficacy data with pudafensine	07/11
Initiator Pharma - Positive Phase IIb results	10/10/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Initiator Pharma A/S

Actions

INIT

DK0060775872

Autres langues

Filtres